KU Leuven Innovation & Entrepreneurship

0 employees

On July 3, 2002 the Gemma Frisius Fund II was established. Continuing the work of its predecessor Gemma Frisius Fund I, this is a venture

Investor insights

Sectors invested in

Biotechnology9

Chemical6

Software6

Information Technology4

Health Care4

Analytics4

Manufacturing4

Artificial Intelligence3

Oil and Gas3

Research and development3

Microbiology3

biostimulants3

Agriculture3

biologicals3

biocontrol3

Big Data2

Business Intelligence2

Predictive Analytics2

Data Mining2

Genetics2

Funding rounds participated in

$4.7M sweet spot round size

Most of their 28 investments are in rounds between $1.2M and $8.6M

Basic info

Industry

research services

Sectors

innovation

spin-off creation

licensing opportunities

research collaboration

KU Leuven

technology transfer

entrepreneurship

intellectual property rights

knowledge driven development

Date founded

1972

Investments made

dualyx raised $44M on May 15, 2023

Investors: V-Bio Ventures, Andera Partners, Forbion, High-Tech Gründerfonds, BGV (BioGeneration Ventures), VIB and KU Leuven Innovation & Entrepreneurship

Rewind Therapeutics raised undisclosed on January 25, 2023

Investors: Sunstone Life Science Ventures, M Ventures and KU Leuven Innovation & Entrepreneurship

MyCellHub raised $2.1M on December 15, 2022

Investors: The Faktory Fund, - and KU Leuven Innovation & Entrepreneurship

AstriVax raised $30M on August 25, 2022

Investors: V-Bio Ventures, Merieux Equity Partners, Ackermans & van Haaren, Thuja Capital, BNP Paribas Fortis, FundPlus and KU Leuven Innovation & Entrepreneurship

Aphea.Bio raised $22M on April 14, 2021

Investors: Vives Louvain Technology Fund, V-Bio Ventures, European Circular Bioeconomy Fund, VIB and KU Leuven Innovation & Entrepreneurship

Aphea.Bio raised $4.7M on April 1, 2021

Investors: Vives Louvain Technology Fund, European Circular Bioeconomy Fund, VIB, Qbic and KU Leuven Innovation & Entrepreneurship

Runeasi raised $409K on November 1, 2020

Investors: KU Leuven Innovation & Entrepreneurship

ViroVet raised $6.6M on May 28, 2020

Investors: KU Leuven, Capricorn Venture Partners, Seventure Partners and KU Leuven Innovation & Entrepreneurship

Augustine Therapeutics raised $4.7M on December 16, 2019

Investors: VIB, AdBio partners, V-Bio Ventures and KU Leuven Innovation & Entrepreneurship

MyCellHub raised $1.2M on September 12, 2019

Investors: -, KU Leuven, The Faktory Fund and KU Leuven Innovation & Entrepreneurship